Sales for Krka and Lek, the two largest pharmaceutical companies in Slovenia, rose by 10.2% and 51.9% in 2003 to reach Tol97 billion and Tol145 billion, respectively

Author:  

Publisher: Adis International

ISSN: 1173-5503

Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.447, 2004-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract